A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
Abstract Background Merkel cell carcinomas (MCCs) are rare, aggressive, therapeutically-challenging skin tumours that are increasing in incidence and have poor survival rates. The majority are caused by genomic Merkel cell polyomavirus (MCPyV) integration and MCPyV T-antigen expression. Recently, a...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2019-10-01
|
| Серія: | Journal of Experimental & Clinical Cancer Research |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s13046-019-1425-3 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|